Skip to main content
Premium Trial:

Request an Annual Quote

MultiPlan Providing its Members Access to Response Genetics' MDx Tests

NEW YORK (GenomeWeb News) – Response Genetics today announced an agreement with managed healthcare firm MultiPlan to provide its members with access to Response's molecular diagnostic tests.

MultiPlan has about 67 million consumers accessing its provider network products, and it contracts with more than 900,000 healthcare providers across the US, Response said.

Today's deal is the third announced recently by Response with a payor, following agreements with Blue Cross Blue Shield of Illinois in July and Blue Shield of California in May. The Los Angeles-based company last week announced a 39 percent jump in revenues for its second quarter.

Financial and other details of the agreement with MultiPlan were not disclosed.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.